| Code | 2403A | ||||||||||
| MA number | 44/0362/12-S | ||||||||||
| Product Form: | tbl flm 180x500 mg (blis.Al/Al) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 20.08.2012 |
| SPC: |
SPC_Capecitabine STADA_04/2021.pdf
|
| PIL: |
PIL_Capecitabine STADA_05.2023.pdf
|
| Safety feature | Yes |
| Data update: | 26.09.2018 |
